We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

No tears formula

12 Nov 2021 By Aimee Donnellan, Robert Cyran

The $429 bln maker of shampoo and vaccines is splitting in two. A valuation uplift looks likely as consumer giants like P&G fetch higher multiples than pharma groups. Giving the business a separate life, with its own currency, opens the door to other possibilities, including M&A.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)